354 related articles for article (PubMed ID: 12162432)
1. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive.
Dhar A; Young MR; Colburn NH
Mol Cell Biochem; 2002; 234-235(1-2):185-93. PubMed ID: 12162432
[TBL] [Abstract][Full Text] [Related]
2. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis.
Hsu TC; Young MR; Cmarik J; Colburn NH
Free Radic Biol Med; 2000 May; 28(9):1338-48. PubMed ID: 10924853
[TBL] [Abstract][Full Text] [Related]
3. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation.
Hsu TC; Nair R; Tulsian P; Camalier CE; Hegamyer GA; Young MR; Colburn NH
Cancer Res; 2001 May; 61(10):4160-8. PubMed ID: 11358840
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the antioxidative property of morusin in blocking phorbol ester-induced malignant transformation of JB6 P
Cheng PS; Hu CC; Wang CJ; Lee YJ; Chung WC; Tseng TH
Chem Biol Interact; 2017 Feb; 264():34-42. PubMed ID: 28108223
[TBL] [Abstract][Full Text] [Related]
5. Red Ginseng Oil Inhibits TPA-Induced Transformation of Skin Epidermal JB6 Cells.
Truong VL; Kong AN; Jeong WS
J Med Food; 2018 Apr; 21(4):380-389. PubMed ID: 29271701
[TBL] [Abstract][Full Text] [Related]
6. AP-1, NF-kappa-B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model.
Suzukawa K; Weber TJ; Colburn NH
Environ Health Perspect; 2002 Sep; 110(9):865-70. PubMed ID: 12204819
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response.
Li JJ; Westergaard C; Ghosh P; Colburn NH
Cancer Res; 1997 Aug; 57(16):3569-76. PubMed ID: 9270030
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.).
Wang SY; Feng R; Lu Y; Bowman L; Ding M
J Agric Food Chem; 2005 May; 53(10):4187-93. PubMed ID: 15884858
[TBL] [Abstract][Full Text] [Related]
9. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells.
Hu J; Nakano H; Sakurai H; Colburn NH
Carcinogenesis; 2004 Oct; 25(10):1991-2003. PubMed ID: 15192014
[TBL] [Abstract][Full Text] [Related]
10. Humic acid in drinking well water induces inflammation through reactive oxygen species generation and activation of nuclear factor-κB/activator protein-1 signaling pathways: a possible role in atherosclerosis.
Hseu YC; Senthil Kumar KJ; Chen CS; Cho HJ; Lin SW; Shen PC; Lin CW; Lu FJ; Yang HL
Toxicol Appl Pharmacol; 2014 Jan; 274(2):249-62. PubMed ID: 24239652
[TBL] [Abstract][Full Text] [Related]
11. Omega 3 but not omega 6 fatty acids inhibit AP-1 activity and cell transformation in JB6 cells.
Liu G; Bibus DM; Bode AM; Ma WY; Holman RT; Dong Z
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7510-5. PubMed ID: 11416221
[TBL] [Abstract][Full Text] [Related]
12. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
13. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
[TBL] [Abstract][Full Text] [Related]
14. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation.
Yang HS; Jansen AP; Nair R; Shibahara K; Verma AK; Cmarik JL; Colburn NH
Oncogene; 2001 Feb; 20(6):669-76. PubMed ID: 11314000
[TBL] [Abstract][Full Text] [Related]
15. Silibinin inhibits UVB- and epidermal growth factor-induced mitogenic and cell survival signaling involving activator protein-1 and nuclear factor-kappaB in mouse epidermal JB6 cells.
Singh RP; Dhanalakshmi S; Mohan S; Agarwal C; Agarwal R
Mol Cancer Ther; 2006 May; 5(5):1145-53. PubMed ID: 16731746
[TBL] [Abstract][Full Text] [Related]
16. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.
Young MR; Nair R; Bucheimer N; Tulsian P; Brown N; Chapp C; Hsu TC; Colburn NH
Mol Cell Biol; 2002 Jan; 22(2):587-98. PubMed ID: 11756554
[TBL] [Abstract][Full Text] [Related]
17. Effects of polyphenols derived from fruit of Crataegus pinnatifida on cell transformation, dermal edema and skin tumor formation by phorbol ester application.
Kao ES; Wang CJ; Lin WL; Chu CY; Tseng TH
Food Chem Toxicol; 2007 Oct; 45(10):1795-804. PubMed ID: 17493734
[TBL] [Abstract][Full Text] [Related]
18. The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
Ma C; Wang J; Gao Y; Gao TW; Chen G; Bower KA; Odetallah M; Ding M; Ke Z; Luo J
Cancer Res; 2007 Aug; 67(16):7756-64. PubMed ID: 17699780
[TBL] [Abstract][Full Text] [Related]
19. Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation.
Dhar A; Hu J; Reeves R; Resar LM; Colburn NH
Oncogene; 2004 May; 23(25):4466-76. PubMed ID: 15064752
[TBL] [Abstract][Full Text] [Related]
20. Humulone inhibits phorbol ester-induced COX-2 expression in mouse skin by blocking activation of NF-kappaB and AP-1: IkappaB kinase and c-Jun-N-terminal kinase as respective potential upstream targets.
Lee JC; Kundu JK; Hwang DM; Na HK; Surh YJ
Carcinogenesis; 2007 Jul; 28(7):1491-8. PubMed ID: 17372274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
